MIR1185-2: A Drug Target / Disease Biomarker (G100302209)
MIR1185-2: A Drug Target / Disease Biomarker
MIR1185-2 is a protein that is expressed in various tissues of the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the MIR family of proteins, which are known for their role in the regulation of inflammation and cellular signaling.
One of the functions of MIR1185-2 is to regulate the production of pro-inflammatory cytokines, which are important mediators of inflammation and tissue damage. MIR1185-2 has been shown to interact with several different cytokines, including TNF-alpha, IL-1, and IL-6.
In addition to its role in cytokine regulation, MIR1185-2 has also been shown to play a key role in the development and progression of several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
One of the reasons for the interest in MIR1185-2 is its potential as a drug target. Because MIR1185-2 is involved in the regulation of pro-inflammatory cytokines, targeting this protein with small molecules or other compounds that can modulate its activity could potentially lead to the development of new treatments for a variety of diseases.
One approach to targeting MIR1185-2 is to use small molecules that can modulate its activity. One such approach is the use of inhibitors of the nuclear factor kappa B (NFkB), which is a protein that is involved in the regulation of multiple cellular processes, including inflammation and cell survival.
Nuclear factor kappa B is a protein that is expressed in various tissues of the body and is involved in the regulation of multiple cellular processes, including the production of pro-inflammatory cytokines. MIR1185-2 is known to interact with NFkB, and inhibitors of NFkB have been shown to be effective in modulating the activity of MIR1185-2.
Another approach to targeting MIR1185-2 is to use antibodies that can specifically recognize and target the protein. One such approach is the use of monoclonal antibodies (MCAs), which are antibodies that are produced by a single cell and can be directed to specific protein targets.
MCAs have been shown to be effective in targeting MIR1185-2 and modulating its activity. By using antibodies that recognize MIR1185-2, researchers have been able to block its activity and demonstrate that this protein plays a key role in the regulation of pro-inflammatory cytokines.
In conclusion, MIR1185-2 is a protein that is involved in the regulation of multiple cellular processes and has been shown to play a key role in the development and progression of several diseases. As a potential drug target, MIR1185-2 is an attractive target for the development of new treatments for a variety of conditions. The use of small molecules or antibodies that can modulate its activity could lead to the development of new treatments for a range of diseases.
Protein Name: MicroRNA 1185-2
More Common Targets
MIR1193 | MIR1197 | MIR1199 | MIR1200 | MIR1202 | MIR1203 | MIR1204 | MIR1205 | MIR1206 | MIR1207 | MIR1208 | MIR12129 | MIR12135 | MIR12136 | MIR122 | MIR1224 | MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237 | MIR1238 | MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2 | MIR129-1 | MIR129-2
